Skip to main content

Table 2 Clinical and mycological evaluation of the antifungal activity of the piroctone olamine in experimental intra-abdominal candidiasis

From: Antifungal activity of the piroctone olamine in experimental intra-abdominal candidiasis

Control group versus treatment group
Rat/number FG scoring
Liver Spleen Kidneys
Control
1 1 0 1
2 1 1 1
3 1 0 1
4 1 1 0
5 1 1 0
6 1 0 0
PO
1 0 1 0
2 0 1 0
3 0 0 0
4 1 0 0
5 1 0 0
6 1 0 0
AMB
1 0 0 0
2 1 0 0
3 0 0 0
4 1 1 0
5 0 0 0
6 1 0 0
  1. PO piroctone olamine, AMB amphotericin B, FG fungal growth in culture media: (0) no fungal growth and (1) fungal growth